Medable reaches $2.1B valuation as Tiger, Blackstone, GSR pump new capital into clinical trials management company

Medable has grown 300% in the past year and over 800% in the last 18 months, which CEO Michelle Longmire said was proof that a patient-centered approach is taking hold....